Mednet Logo
HomePulmonologyQuestion

How do you choose between azithromycin and roflumilast in the management of a patient with severe COPD who remains symptomatic with frequent exacerbations despite maximal dose LABA/LAMA/ICS with demonstrated compliance and proper inhaler technique?

1 Answers
Mednet Member
Mednet Member
Pulmonology · McLaren Port Huron Pulmonology Critical Care And Sleep Medicine

Zithromax 250 mg on Monday, Wednesday, and Friday. I would consider roflumilast only in patients who are phenotypically and physiologically chronic bronchitis patients.

Register or Sign In to see full answer

How do you choose between azithromycin and roflumilast in the management of a patient with severe COPD who remains symptomatic with frequent exacerbations despite maximal dose LABA/LAMA/ICS with demonstrated compliance and proper inhaler technique? | Mednet